Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Aclarubicin

Aclarubicin

pharmaceutical raw materials
Aclarubicin structure

Aclarubicin 

structure
  • CAS No:

    57576-44-0

  • Formula:

    C42H53NO15

  • Chemical Name:

    Aclarubicin

  • Synonyms:

    1-Naphthacenecarboxylic acid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-,methyl ester,(1R,2R,4S)-;1-Naphthacenecarboxylic acid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-,methyl ester,[1R-(1α,2β,4β)]-;Aclacinomycin A;Antibiotic MA 144A1;Aclarubicin;NSC 208734;Antibiotic 77-3082A;Antibiotic 3082A;Aclacur;Jaclacin;72711-48-9

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

ChEBI: An anthracycline antibiotic that is produced by Streptomyces galilaeus and also has potent antineoplastic activity.

Aclarubicin Basic Attributes

811.87

811.87

260-824-3

DTXSID1022554

Characteristics

217.05000

3.15770

1.42 g/cm3

151-153 °C (decomp)

897.7ºC at 760 mmHg

496.7ºC

1.629

2-8°C

Oral-rat LD50: 58.56 mg/kg; Oral-Mouse LD50: 16.1mg/kg

Flammable; burning produces toxic nitrogen oxide fumes

D24 -11.5° (c = 1 in methylene chloride)

Safety Information

II

6.1(a)

3249

25

36/37/39-45

QI9279300

T

Treasury is ventilated, low temperature and dry; stored separately from food materials

|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory.

Toxicity

most toxic

Aclarubicin Use and Manufacturing

Methods of Manufacturing

It is produced by fermentation and produces Streptomyces galilacus. First prepare an aqueous solution containing the following substances: 1% potato flour, 1% glucose, 1.5% Prorich, 0.1% KH2PO4, 0.1% KH2PO4, 0.1% MgSO4 7H2O, 0.3% NaCl, 0.15% compound Minerals and 0.05% silicone (KM75), the Ph value of the aqueous solution is 7.0. The composition of the composite minerals is: 2.8g CuSO4?5H2O, 0.4g FeSO4?7H2O, 3.2g MnCl2?4H2O and 0.8g ZnSO4?7H2O dissolved in 500ml water. 100ml of the above aqueous solution was sterilized in a 500ml shaker bottle with Streptomyces galilaeus MA 144-M1 strain at 120°C for 15 minutes. In a reciprocating shaker, culture was carried out at 28°C for 48 hours to obtain seed liquid. The above 10L disinfectant was put into a 20L stainless steel fermentation tank and inoculated with 200ml of seed liquid. Under stirring (240r/min) and aeration (5L/min) and 28°C, fermentation was carried out for 32h. Adjust to Ph=4.5, mix with diatomaceous earth adsorbent, and filter. The filtrate and filter cake of the fermentation broth are treated separately. The filter cake was suspended in acetone (3L/kg wet cake), stirred for 2 hours and filtered, and the filter cake was extracted with acetone once more. The extract thus obtained was concentrated under reduced pressure to 1/10 volume. The filtrate of the fermentation broth was adjusted to Ph=6.8, extracted twice with 1/3 volume of ethyl acetate, and the extract was concentrated to 1/10 volume under reduced pressure. The obtained 20 g oily substance and 20 g silicic acid were mixed, and chromatographed with a silicic acid column, first eluting with 1:1 phenyl-acetone, and the eluate was discarded. Then it was eluted with benzene-acetone-methanol at 1:3:0 and 1:3:0.3, collected, and concentrated under reduced pressure to dryness. The remaining 11.5 g of crude product was dissolved in a small amount of ethyl acetate, and then subjected to silicic acid column chromatography as above, and the first 1:1 and 2:1 benzene-acetone eluent was discarded. Aclamycin B was eluted with 1:3 and 1:5 phenyl-acetone, and then arubicin was eluted with 1:5:0.5 and 1:5:1 phenyl-acetone-methanol. The eluate was dried with anhydrous sodium sulfate and concentrated to dryness under reduced pressure to obtain 4.8 g of arubicin (Aclarithromycin A) and 3.5 g of aclarithromycin B crude products. 2.0g crude arubicin was dissolved in a small amount of chloroform, and 30g silica gel was used for column chromatography. The impurities were first eluted with chloroform and a chloroform solution containing 1.5% methanol, and then a chloroform solution containing 2% methanol Bixin eluted. The eluate was concentrated to dryness under reduced pressure to obtain 53 mg of arubicin as a yellow powder with a melting point of 129-135°C.

Uses

Antitumor antibiotics, mainly used for lung cancer, breast cancer, digestive tract cancer, acute leukemia, etc.

Computed Properties

Molecular Weight:811.9
XLogP3:3.8
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:16
Rotatable Bond Count:10
Exact Mass:811.34151998
Monoisotopic Mass:811.34151998
Topological Polar Surface Area:217
Heavy Atom Count:58
Complexity:1530
Undefined Atom Stereocenter Count:13
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

Aclarubicin is a new anthracycline antitumor antibiotic, which has strong antitumor activity against various transplanted animal tumors such as L310, P388, Ehlrich ascites carcinoma, Lewis lung cancer, S100 sarcoma, B16 melanoma and CDF8, C3H breast cancer. This product can inhibit the biomacromolecule synthesis of cancer cells, especially the inhibition of RNA synthesis. It has certain cardiotoxicity and bone marrow suppression effects on experimental animals, but the effects are reversible. This product has reproductive toxicity.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Aclarubicin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.